Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose ciprofol pretreatment to inhibit etomidate-induced tracheal intubation response
ChiCTR2300077996Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Nov 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Positive rate of cardiovascular reaction during tracheal intubation. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2300077996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077996.